Publication:
Dupilumab treatment in adult patients with moderate to severe atopic dermatitis: A real-world single-center experience from Turkey

dc.contributor.authorsSalman, Andac; Aktas, Meryem; Ozkurkcu, Esra; Sarac, Gonca; Taskapan, Oktay; Ergun, Tulin
dc.date.accessioned2022-03-12T16:24:39Z
dc.date.accessioned2026-01-11T06:19:17Z
dc.date.available2022-03-12T16:24:39Z
dc.date.issued2020
dc.identifier.doidoiWOS:000598634300577
dc.identifier.eissn1097-6787
dc.identifier.issn0190-9622
dc.identifier.urihttps://hdl.handle.net/11424/226413
dc.identifier.wosWOS:000598634300577
dc.language.isoeng
dc.publisherMOSBY-ELSEVIER
dc.relation.ispartofJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDupilumab treatment in adult patients with moderate to severe atopic dermatitis: A real-world single-center experience from Turkey
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageAB144
oaire.citation.issue6
oaire.citation.startPageAB144
oaire.citation.titleJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
oaire.citation.volume83

Files